Medical Economics November 26, 2024
Richard Payerchin

Will it take effect? Biden proposal would be finalized in Trump’s term, and his pick to lead HHS has spoken against antiobesity drugs.

Medicare Part D and Medicaid would expand drug coverage to include new antiobesity medications, according to a proposal by the administration of President Joe Biden.

The U.S. Centers for Medicare & Medicaid Services (CMS) announced the proposal for the contract year 2026 proposed rule for Medicare Advantage and Medicare Part D. The rule aims to hold the plans “more accountable for delivering high-quality coverage so that people with Medicare are connected to the care they need when they need it,” the announcement said.

Allowing the coverage would change a policy in place more than 20 years. The...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, CMS, Govt Agencies, Insurance, Medicaid, Medicare, Patient / Consumer, Pharma / Biotech
Related Articles:
CMS Launches New Program for Mental Health, OUD Treatment
How Medicare Negotiated Drug Prices Compare to Other Countries
Telehealth groups call for urgent action as Medicare flexibility deadline looms
Innovating Without Compromising Integration: Considerations For Medicare
How the Federal Government Could Push People Toward Medicare Advantage – And Replace Traditional Medicare

Share This Article